#3-Smiley Riley(#698510) -From your link (thank yo
Post# of 148184
(Total Views: 716)
Posted On: 12/27/2020 11:09:32 PM
#3-Smiley Riley(#698510) -From your link (thank you)
"So critical care patients can get eIND's if they aren't at one of the clinical trial sites. All the doctors in the current sites should get their patients enrolled ASAP. What makes this announcement so powerful is that the doctors in this study were blinded. They thought it was working but after they enroll a couple of patients they will know it is working and this word will spread like wild fire. I expect patient recruitment to go through the roof next week.
"This impending EUA / outright approval is long overdue. With over 100 miraculous EIND stories, 5 trials for Mild/Moderate & Severe Critical, 2 publications, countless 'ambassadors of Leronlimab or Vyrologix its brand name including the likes of Dr Bruce Patterson among many others.
"To anyone with a loved one in the hospital with Covid19 or suffering from Covid Longhaulers symptoms I highly suggest asking your doctor for this incredible monoclonal antibody treatment. This therapy targets the CCR5 cell and reduces the viral load in days! I strongly believe it should have gotten approval by NIH, OWS and FDA many months ago as it concluded MM trials in May.
Not going to get into political corruption theory here but Big Pharma came first w 3 drugs that don't work. Read into it what you will. Many stories will be written about this in the months to come. God only knows how many lives could have been saved had Leronlimab been allowed to go to market back in June...just around the time that Gileads Remdesivir trumped over CytoDyns Leronlimab....hmm, very odd eh. Remdesivir was ruled by OWS as ineffective for those unaware.
"So critical care patients can get eIND's if they aren't at one of the clinical trial sites. All the doctors in the current sites should get their patients enrolled ASAP. What makes this announcement so powerful is that the doctors in this study were blinded. They thought it was working but after they enroll a couple of patients they will know it is working and this word will spread like wild fire. I expect patient recruitment to go through the roof next week.
"This impending EUA / outright approval is long overdue. With over 100 miraculous EIND stories, 5 trials for Mild/Moderate & Severe Critical, 2 publications, countless 'ambassadors of Leronlimab or Vyrologix its brand name including the likes of Dr Bruce Patterson among many others.
"To anyone with a loved one in the hospital with Covid19 or suffering from Covid Longhaulers symptoms I highly suggest asking your doctor for this incredible monoclonal antibody treatment. This therapy targets the CCR5 cell and reduces the viral load in days! I strongly believe it should have gotten approval by NIH, OWS and FDA many months ago as it concluded MM trials in May.
Not going to get into political corruption theory here but Big Pharma came first w 3 drugs that don't work. Read into it what you will. Many stories will be written about this in the months to come. God only knows how many lives could have been saved had Leronlimab been allowed to go to market back in June...just around the time that Gileads Remdesivir trumped over CytoDyns Leronlimab....hmm, very odd eh. Remdesivir was ruled by OWS as ineffective for those unaware.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼